Indegene gains $200m backing for expansion plans

Indegene has struck a deal with two investment companies that will see them take a $200 million minority stake in the healthtech company.

The funding from The Carlyle Group and Brighton Park Capital will pave the way for Indegene to accelerate its global expansion and consolidate its position in healthtech solutions, the firm said.